136 related articles for article (PubMed ID: 29520977)
1. The role of primary lymph node sites in survival and mortality prediction in Hodgkin lymphoma: a SEER population-based retrospective study.
Ebied A; Thanh Huan V; Makram OM; Sang TK; Ghorab M; Ngo HT; Iraqi A; Kamel MG; Dang TN; Vuong NL; Hirayama K; Huy NT
Cancer Med; 2018 Apr; 7(4):953-965. PubMed ID: 29520977
[TBL] [Abstract][Full Text] [Related]
2. Primary lymph node sites in Hodgkin lymphoma and the risk of second primary cancers: a population-based study.
Ebied A; Yousif M; Nam NH; Elhamamsy AR; Hassan OG; Mostafa EM; Nguyen GJ; Hirayama K; Huy NT
Future Oncol; 2020 Mar; 16(9):451-467. PubMed ID: 32096658
[No Abstract] [Full Text] [Related]
3. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
4. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
Coburn NG; Swallow CJ; Kiss A; Law C
Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
[TBL] [Abstract][Full Text] [Related]
5. Improved survival time trends in Hodgkin's lymphoma.
Koshy M; Fairchild A; Son CH; Mahmood U
Cancer Med; 2016 Jun; 5(6):997-1003. PubMed ID: 26999817
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases.
Laurent C; Do C; Gourraud PA; de Paiva GR; Valmary S; Brousset P
Medicine (Baltimore); 2015 Jun; 94(25):e987. PubMed ID: 26107683
[TBL] [Abstract][Full Text] [Related]
7. Mortality and survival patterns of childhood lymphomas: geographic and age-specific patterns in Southern-Eastern European and SEER/US registration data.
Karalexi MA; Georgakis MK; Dessypris N; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Demetriou A; Agius D; Florea M; Coza D; Bouka E; Dana H; Hatzipantelis E; Kourti M; Moschovi M; Polychronopoulou S; Stiakaki E; Pourtsidis A; Petridou ET
Hematol Oncol; 2017 Dec; 35(4):608-618. PubMed ID: 27641612
[TBL] [Abstract][Full Text] [Related]
8. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of lymph nodes count on survival of patients with node-negative gastric cancer.
Zheng WF; Ji TT; Lin Y; Li RZ
Oncotarget; 2016 Jul; 7(28):43680-43688. PubMed ID: 27270656
[TBL] [Abstract][Full Text] [Related]
10. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
[TBL] [Abstract][Full Text] [Related]
13. Interaction between Age and Primary Site on Survival Outcomes in Primary GI Melanoma over the Past Decade.
Bangolo A; Fwelo P; Sagireddy S; Shah H; Trivedi C; Bukasa-Kakamba J; Patel R; Bharane L; Randhawa MK; Nagesh VK; Dey S; Terefe H; Kaur G; Dinko N; Emiroglu FL; Mohamed A; Fallorina MA; Kosoy D; Waqar D; Shenoy A; Ahmed K; Nanavati A; Singh A; Willie A; Gonzalez DMC; Mukherjee D; Sajja J; Proverbs-Singh T; Elias S; Weissman S
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218984
[TBL] [Abstract][Full Text] [Related]
14. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
15. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
Milano MT; Li H; Constine LS; Travis LB
Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
[TBL] [Abstract][Full Text] [Related]
16. Predictors of axillary lymph node involvement in women with T3 breast cancers: analysis of 1988-2003 SEER data.
Fields RC; Jeffe DB; Deshpande AD; Feunou F; Krishna N; Margenthaler JA
J Surg Res; 2010 Jun; 161(2):183-9. PubMed ID: 19959188
[TBL] [Abstract][Full Text] [Related]
17. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
19. Patterns of care and survival outcomes examining radiation therapy for advanced Hodgkin lymphoma.
Son CH; Chiu BC; Koshy M
Leuk Lymphoma; 2017 Feb; 58(2):343-347. PubMed ID: 27339611
[TBL] [Abstract][Full Text] [Related]
20. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]